Internationale samarbejder

 

  • The effect of JAK inhibitors on venous thromboembolism and viral infection risk in patients with rheumatoid arthritis. Lene Wohlfahrt Dreyer, René Cordtz. Collaborators: Andrea Burden, Maria Luisa Marques de Sá Faquetti, Vallejo Yagüe Enriqueta

  • EULAR portfolio for training in rheumatology: a EULAR School of Rheumatology initiative. Mette Holland-Fischer. Collaborators: Marloes van Onna, Sofia Ramiro, Catherine Haines, Jose da Silva, Jean Dudler, Chris Edwards, Alessia Alunno, Elena Nikiphorou, Louise Falzon, Francisca Sivera: Working group on Development of a EULAR portfolio of Rheumatology

  • Task Force for the development of EULAR recommendations for a core data set to support research and clinical care in SLE. Lene Wohlfahrt Dreyer. Collaborators: EULAR Task Force group
  • Global disparities in biosimilar uptake in patients with rheumatoid arthritis. Lene Wohlfahrt Dreyer. Collaborators: Merete Lund Hetland, Sytske Anne Bergstra
  • Mortality from interstitial lung disease in rheumatoid arthritis - a collaborative study from the Nordic countries. Lene Wohlfahrt Dreyer. Collaborators: Sella Aarrestad Provan, Eirik Ikdahl, Lotta Ljung, Brigitte Michelsen, Till Uhlig, Thorarinn Jonmundsson, Björn Gudbjornsson, Daniela Di Giuseppe, Merete Lund Hetland, Guðrún Björk Reynisdóttir, Bente Glintborg, Heikki Relas, Kalle Aaltonen, Dan Nordström, Tore K. Kvien, Johan Askling 
  • Study of anxiety/depression and suicidality among patients with PsA and axSpA in the Nordic countries. Lene Wohlfahrt Dreyer. Collaborators: Brigitte Michelsen, Sella Aarrestad Provan, Joe Sexton, Tore K. Kvien, Johan K. Wallman, Daniela Di Giuseppe, Bénédicte Delcoigne, Johan Askling, Johan Reutfors, Bente Glintborg, Merete Lund Hetland, Jette Heberg, Björn Gudbjornsson, Olafur Palsson, Thorarinn Jonmundsson
  • The effect of JAK inhibitors – The JAKPOT Consortium. Lene Wohlfahrt Dreyer, René Cordtz, Rasmus Westermann. Collaborators: Kim Lauper, Denis Mongin, Sytske Anne Bergstra, Denis Choquette, Catalin Codreanu, Diederik De Cock, Ori Elkayam, Kimme Hyrich, Florenzo Iannone, Nevsun Inanc, Eirik K. Kristianslund, Tore K. Kvien, Burkhard Leeb, Galina Lukina, Dan Nordström, Karel Pavelka, Manuel Pombo-Suarez, Ziga Rotar, Maria Jose Santos, Anja Strangfeld, Delphine Courvoisier, Axel Finckh 

  • The BIODOPT study. Line Uhrenholt, Salome Kristensen, Lene W Dreyer. Collaborator Professor Peter Taylor 
  • Giant cell arteritis and the risk of Diabetes mellitus. Mads ER Sørensen, Salome Kristensen, Line Uhrenholt, Lene W Dreyer. Collaborators Professor Peter Villiger and Lisa Christ.
  • ScandRA project to facilitate collaborative studies based on linkages of clinical data, biomarkers and genetics with national health register data. Salome Kristensen, Collaborators:  Bente Glintborg, Merete Hetland, Saedis Saevarsdottir, Johan Askling, Helga Westerlind, Hilda Hammer.

  • Task Force for the development of EULAR recommendations for Tapering biologics, Salome Kristensen, Line Uhrenholt, Collaborators: EULAR Task Force group

  • Task Force for the development of EULAR recommendations for GCA/PMR, Salome Kristensen, Mads ER Sørensen, Collaborators: EULAR Task Force group

  • Task Force for the development of EULAR recommendations for MCTD (initiation phase), Salome Kristensen, Lene W Dreyer, Collaborators: EULAR Task Force group

  • Risk of non-melanoma skin cancer in patients with psoriatic arthritis and according to bDMARD treatment – A cohort study from the Nordic Arthritis Research Collaboration. : Rasmus Westermann, Bénédicte Delcoigne, René Lindholm Cordtz, Sella Aarrestad Provan, Joe Sexton, Dan Nordström, Pia Isomäk6, Kalle Aaltonen, Johan Askling, Lene Wohlfahrt Dreyer, Karin Hellgren8
     
     

 

Opdateret